NAYA Biosciences Long Term Debt 2010-2024 | IVF

NAYA Biosciences long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
NAYA Biosciences Annual Long Term Debt
(Millions of US $)
2024 $1
2023 $1
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
NAYA Biosciences Quarterly Long Term Debt
(Millions of US $)
2024-12-31 $1
2024-09-30 $1
2024-06-30 $1
2024-03-31 $1
2023-12-31 $1
2023-09-30 $1
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30 $1
2020-06-30 $1
2020-03-31
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31
2018-12-31
2018-09-30
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.001B $0.007B
NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.
Stock Name Country Market Cap PE Ratio
MYT Netherlands Parent B.V (LUXE) DE $0.643B 0.00
CAPITA (CTAYD) GB $0.274B 0.00
SAG Holdings (INEO) SG $0.013B 0.00
Aerovate Therapeutics (JBIO) US $0.010B 0.00